Lactoferrin promotes healthy growth of infants and young children

Our reporter Wang Wei

Lactoferrin became a hot topic at the 2nd Breast Milk Science Conference held recently

Promote the clinical application of lactoferrin

The "Chinese Expert Consensus on the Clinical Application of Lactoferrin" (hereinafter referred to as the "Consensus") released on August 6 also further confirmed the clinical utility of lactoferrin

Professor Chen Wei, chairman of the Clinical Nutrition Branch of the Chinese Nutrition Society and chief physician of the Department of Clinical Nutrition, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, who participated in the preparation of the consensus, affirmed the clinical value of the consensus

Lai Jianqiang, deputy director of the Institute of Nutrition and Health of the Chinese Center for Disease Control and Prevention, said that the formation of the immune barrier of infants and young children is inseparable from scientific feeding methods

Lactoferrin builds immune barrier for "early 1000 days of life"

At the meeting, Dianne Delsing, senior researcher of FrieslandCampina Nutrition and Health, shared the cutting-edge research results of lactoferrin, introduced the role of lactoferrin in early life immunity, and elaborated on the role of lactoferrin in regulating immunity, anti-virus and reducing infant Mechanisms of action in the risk of respiratory and gastrointestinal infections in young children

Dianne Delsing points out that the "first 1,000 days of life" from a woman's conception to the birth of her baby are critical to healthy development

Relevant clinical studies have shown that lactoferrin can reduce the risk of intestinal infection, help control oral hygiene, inhibit the growth of intestinal pathogens, and have antibacterial, antiviral, and anti-inflammatory effects

Responsible editor: Zhang Jiazhen Review: Wang Jinchen